Morgan Stanley
LONA

Morgan Stanley’s LeonaBio Inc LONA Stock Holding History

Morgan Stanley’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$818 Sell
89
-382
-81% -$3.56K ﹤0.01% 7535
2026
Q1 		$4.84K Buy
471
+1
+0.2% +$7 ﹤0.01% 7142
2025
Q4 		$3.56K Sell
470
-40
-8% -$183 ﹤0.01% 7128
2025
Q3 		$2.11K Sell
510
-1
-0.2% -$4 ﹤0.01% 7293
2025
Q2 		$1.54K Hold
511
– – ﹤0.01% 7276
2025
Q1 		$1.46K Sell
511
-90
-15% -$399 ﹤0.01% 7233
2024
Q4 		$3.53K Sell
601
-2,800
-82% -$15.8K ﹤0.01% 7093
2024
Q3 		$15.2K Buy
3,401
+1,081
+47% +$25.4K ﹤0.01% 6593
2024
Q2 		$61.5K Sell
2,320
-1,930
-45% -$45.5K ﹤0.01% 6112
2024
Q1 		$116K Sell
4,250
-706
-14% -$22.4K ﹤0.01% 5928
2023
Q4 		$120K Sell
4,956
-1,251
-20% -$22.2K ﹤0.01% 5874
2023
Q3 		$125K Sell
6,207
-5,211
-46% -$133K ﹤0.01% 5776
2023
Q2 		$337K Sell
11,418
-20,720
-64% -$590K ﹤0.01% 5410
2023
Q1 		$803K Buy
32,138
+16,550
+106% +$533K ﹤0.01% 4984
2022
Q4 		$494K Sell
15,588
-4,142
-21% -$131K ﹤0.01% 5260
2022
Q3 		$586K Buy
19,730
+13,118
+198% +$453K ﹤0.01% 5187
2022
Q2 		$202K Sell
6,612
-267
-4% -$24.5K ﹤0.01% 5889
2022
Q1 		$929K Sell
6,879
-2,413
-26% -$254K ﹤0.01% 5050
2021
Q4 		$1.21M Sell
9,292
-8,585
-48% -$1.09M ﹤0.01% 4939
2021
Q3 		$1.68M Sell
17,877
-9,777
-35% -$995K ﹤0.01% 4713
2021
Q2 		$2.83M Buy
27,654
+25,409
+1,132% +$4.44M ﹤0.01% 4345
2021
Q1 		$413K Buy
2,245
+523
+30% +$115K ﹤0.01% 5260
2020
Q4 		$590K Buy
1,722
+1,602
+1,335% +$378K ﹤0.01% 4973
2020
Q3 		$22K Buy
+120
New +$20K ﹤0.01% 6021

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
SSC
Spruce Street Capital New York $510M AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Morgan Stanley's LONA Position: Q2 2026 in Review

Morgan Stanley reduced its LeonaBio Inc (LONA) stake by 81% in Q2 2026, selling an estimated $3.56K and leaving 89 shares worth $818. The position accounts for ﹤0.01% of the portfolio, ranked #7535.

Morgan Stanley first reported a position in LONA in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.83M in Q2 2021. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • Morgan Stanley held 89 shares of LeonaBio Inc worth $818 as of Q2 2026.
  • Morgan Stanley sold 382 LeonaBio Inc shares in Q2 2026, an estimated $3.56K.
  • LeonaBio Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7535 holding.
  • Morgan Stanley first reported a position in LeonaBio Inc in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's LeonaBio Inc position peaked at $2.83M in Q2 2021.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.